tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of James Molloy, 50 are a BUY (94.34%), 2 are a HOLD (3.77%), 1 are a SELL (1.89%).
Analyst James Molloy, currently employed at ALLIANCE GLOBAL PARTNERS, carries an average stock price target met ratio of 46.76% that have a potential upside of 43.06% achieved within 230 days. Previously, James Molloy worked at LAIDLAW, JANNEY, SUMMER STREET.
James Molloy’s has documented 101 price targets and ratings displayed on 19 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on BCDA, Biocardia at 30-Jan-2025.
Analyst best performing recommendations are on TNXP (TONIX PHARMACEUTICALS HOLDING CORP).
The best stock recommendation documented was for TNXP (TONIX PHARMACEUTICALS HOLDING CORP) at 1/12/2023. The price target of $6.5 was fulfilled within 6 days with a profit of $1 (13.33%) receiving and performance score of 22.22.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 03-Aug-2023
$19
$20
2 years 10 months 3 days ago
(27-Sep-2023)
2/8 (25%)
$0.42 (2.26%)
86
Buy Since 12-Jan-2022
$19
$15
2 years 10 months 3 days ago
(27-Sep-2023)
3/16 (18.75%)
$0.42 (2.26%)
57
Buy Since 03-Aug-2023
$19
$19
2 years 10 months 3 days ago
(27-Sep-2023)
11/14 (78.57%)
$0.42 (2.26%)
66
Hold Since 10-Nov-2020
$19
$13
2 years 10 months 3 days ago
(27-Sep-2023)
12/25 (48%)
$0.42 (2.26%)
39
Buy Since 10-Nov-2020
$19
$18
2 years 10 months 4 days ago
(26-Sep-2023)
6/27 (22.22%)
$0.29 (1.55%)
66
What Year was the first public recommendation made by James Molloy?
